Assignee
SHAPE THERAPEUTICS INC
US·2 granted patents·30 pending applications·4 citations·filing 2020–2025
Top patents by PatentIndex Score
32 records- 0185US12054738B2Stable cell lines for inducible production of rAAV virionsSHAPE THERAPEUTICS INC·Filed 2021·Granted Aug 6, 2024·3 cites·32 claims
- 0277US11827880B2Therapeutic editingSHAPE THERAPEUTICS INC·Filed 2020·Granted Nov 28, 2023·1 cites·34 claims
- 0368US2025146020A1Stable Cell Lines for Inducible Production of rAAV VirionsSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0467US2024279650A1Therapeutic EditingSHAPE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0562US2026002177A1High throughput engineering of functional aav capsidsSHAPE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0660US2023048732A1High throughput engineering of functional aav capsidsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0760US2024360473A1Compositions and Methods for AAV ProductionSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0860US2025022532A1Regulating enhancer activity using machine-learningSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0959US2025066774A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1059US2025009904A1RNA-Editing Compositions and Methods of UseSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1158US2025342903A1Methods and systems for transformer-based biological sequence modelsSHAPE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1258US2025026795A1Functional aav capsids for intravitreal administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1357US2025059538A1COMPOSITIONS AND METHODS OF tRNA SILENCINGSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1457US2025205363A1Functional aav capsids for systemic administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1556US2025129127A1Systems for Amplification of AAV Rep and Cap ProteinsSHAPE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1655US2025356949A1Machine-learning based design of engineered guide systems for adenosine deaminase acting on rna editingSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1754US2025084408A1Engineered rnasSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1853US2025109410A1Stable Cell Lines for Inducible Production of rAAV VirionsSHAPE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1952US2024271139A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2052US2024279656A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2151US2024124850A1Auxotrophic Cells for Virus Production and Compositions and Methods of MakingSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2250US2024011028A9Compositions and Methods Using SNRNA ComponentsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2350US2023399635A1RNA-Editing Compositions and Methods of UseSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2449US2023183689A1Compositions and Methods for Genome EditingSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2549US2026069718A1Engineered Guide RNAs and PolynucleotidesSHAPE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2649US2024102083A1High throughput rna-editing screening methodsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2749US2025222139A1Promoter switches for tissue-specific expressionSHAPE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2848US2024238447A1Compositions and methods for modulating payload expression at a transcriptional levelSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2948US2023174977A1Engineered circular polynucleotidesSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3046US2025014676A1Generative sequence screening with conditional gans, diffusion models, and denoising diffusion conditional gansSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3141US2023242910A1Methods and compositions relating to engineered guide systems for adenosine deaminase acting on rna editingSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3237US2023174976A1Targeted rna editing using engineered adenosine deaminase acting on trna (adat) systemsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →